Endothelial-monocyte-activating polypeptide II increases blood-tumor barrier permeability by down-regulating the expression levels of tight junction associated proteins

Brain Research

Volumn 1319, Issue , 2010, Pages 13-20

  Xie, Hui ^a   Xue, Yi xue ^a   Liu, Li bo ^a   Liu, Yun hui ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Blood tumor barrier; Endothelial monocyte activating polypeptide II; Glioma; Tight junction

Indexed keywords

BETA ACTIN; CLAUDIN 5; ENDOTHELIAL MONOCYTE ACTIVATING POLYPEPTIDE II; EVANS BLUE; MESSENGER RNA; OCCLUDIN; PROTEIN ZO1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD TUMOR BARRIER; CONTROLLED STUDY; DOWN REGULATION; EXTRAVASATION; GLIOMA; IMMUNOHISTOCHEMISTRY; NONHUMAN; NUCLEOTIDE SEQUENCE; PERMEABILITY BARRIER; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TIGHT JUNCTION; WESTERN BLOTTING;

ANIMALS; BRAIN NEOPLASMS; CAPILLARY PERMEABILITY; CYTOKINES; DISEASE MODELS, ANIMAL; GLIOMA; MEMBRANE PROTEINS; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; PHOSPHOPROTEINS; RANDOM ALLOCATION; RATS; RATS, WISTAR; RNA, MESSENGER; RNA-BINDING PROTEINS; TIGHT JUNCTIONS; TIME FACTORS;

RATTUS;

EID: 77049086749     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2010.01.023     Document Type: Article

References (40)

1. Andrei I.I., Ingrid C.M., Charles A.P., and Asma N. Role for actin filament turnover and a myosin II motor in cytoskeleton-driven disassembly of the epithelial apical junctional complex. Mol. Biol. Cell 15 (2004) 2639-2651
2. Bamforth S.D., Kniesel U., Wolburg H., Engelhardt B., and Risau W. A dominant mutant of occludin disrupts tight junction structure and function. J. Cell Sci. 112 (1999) 1879-1888
3. Belayev L., Busto R., Zhao W., and Ginsberg M.D. Quantitative evaluation of blood-brain barrier permeability following middle cerebral artery occlusion in rats. Brain Res. 739 (1996) 88-96
4. Berger A.C., Tang G., Alexander H.R., and Libutti S.K. Endothelial monocyte-activating polypeptide II, a tumor-derived cytokine that plays an important role in inflammation, apoptosis, and angiogenesis. J. Immunother. 23 (2000) 519-527
5. Bolton S.J., Anthony D.C., and Perry V.H. Loss of the tight junction proteins occludin and zonula occludens-1 from cerebral vascular endothelium during neutrophil-induced blood-brain barrier breakdown in vivo. Neuroscience 86 (1998) 1245-1257
6. Crippa L., Gasparri A., Sacchi A., Ferrero E., Curnis F., and Corti A. Synergistic damage of tumor vessels with ultra low-dose endothelial-monocyte activating polypeptide-II and neovasculature-targeted tumor necrosis factor-alpha. Cancer Res. 68 (2008) 1154-1161
7. Emerich D.F., Dean R.L., Osborn C., and Bartus R.T. The development of the bradykinin agonist labradimil as a means to increase the permeability of the blood-brain barrier: from concept to clinical evaluation. Clin. Pharmacokinet. 40 (2001) 105-123
8. Farkas E., Süle Z., Tóth-Szu{double acute}ki V., Mátyás A., Antal P., Farkas I.G., Mihály A., and Bari F. Tumor necrosis factor-alpha increases cerebral blood flow and ultrastructural capillary damage through the release of nitric oxide in the rat brain. Microvasc. Res. 72 (2006) 113-119
9. Fischer S., Wobben M., Marti H.H., Renz D., and Schaper W. Hypoxia-induced hyperpermeability in brain microvessel endothelial cells involves VEGF-mediated changes in the expression of zonula occludens-1. Microvasc. Res. 63 (2002) 70-80
10. Fukuhara A., Irie K., Yamada A., Katata T., Honda T., Shimizu K., Akanishi H., and Takai Y. Role of nectin in organization of tight junctions in epithelial cells. Genes Cells 7 (2002) 1059-1072
11. Furuse M., Sasaki H., Fujimoto K., and Tsukita S. A single gene product, claudin-1 or -2, reconstitutes tight junction strands and recruits occludin in fibroblasts. J. Cell Biol. 143 (1998) 391-401
12. Gloor S.M., Wachtel M., Bolliger M.F., Ishihara H., Landmann R., and Frei K. Molecular and cellular permeability control at the blood-brain barrier. Brain Res. Rev. 36 (2001) 258-264
13. Gumbiner B.M. Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell 84 (1996) 345-357
14. Harhaj N.S., and Antonetti D.A. Regulation of tight junctions and loss of barrier function in pathophysiology. Int. J. Biochem. Cell Biol. 36 (2004) 1206-1237
15. Hawkins B.T., Abbruscato T.J., Egleton R.D., Brown R.C., Huber J.D., Campos C.R., and Davis T.P. Nicotine increases in vivo blood-brain barrier permeability and alters cerebral microvascular tight junction protein distribution. Brain Res. 1027 (2004) 48-58
16. Hou Y., Plett P.A., Ingram D.A., Rajashekhar G., Orschell C.M., Yoder M.C., March K.L., and Clauss M. Endothelial-monocyte-activating polypeptide II induces migration of endothelial progenitor cells via the chemokine receptor CXCR3. Exp. Hematol. 34 (2006) 1125-1132
17. Huber J.D., Egleton R.D., and Davis T.P. Molecular physiology and pathophysiology of tight junctions in the blood-brain barrier. Trends Neurosci. 24 (2001) 719-725
18. Inamura T., and Black K.L. Bradykinin selectively opens blood-tumor barrier in experimental brain tumors. J. Cereb. Blood Flow. Metab. 14 (1994) 862-870
19. Keezer S.M., Ivie S.E., Krutzsch H.C., Tandle A., Libutti S.K., and Roberts D.D. Angiogenesis inhibitors target the endothelial cell cytoskeleton through altered regulation of heat shock protein 27 and cofilin. Cancer Res. 63 (2003) 6405-6412
20. Laia C.H., Kuo K.H., and Leo J.M. Critical role of actin in modulating BBB permeability. Brain Res. Rev. 50 (2005) 7-13
21. Lee H.S., Namkoong K., Kim D.H., Kim K.J., Cheng Y.H., Kim S.S., Lee W.B., and Kim K.Y. Hydrogen peroxide-induced alterations of tight junction proteins in bovine brain microvascular endothelial cells. Microvasc. Res. 68 (2004) 231-238
22. Lee N.P., and Cheng C.Y. Regulation of sertoli cell tight junction dynamics in the rat testis via the Nitric oxide synthase/soluble guanylate cyclase/3′5′-cyclic guanosine monophosphate/protein kinase G signaling pathway: an in vitro study. Endocrinology 144 (2003) 3114-3129
23. Liu L.B., Xue Y.X., Liu Y.H., and Wang Y.B. Bradykinin increases blood-tumor barrier permeability by down-regulating the expression levels of ZO-1, occludin, and claudin-5 and rearranging actin cytoskeleton. J. Neurosci. Res. 86 (2008) 1153-1168
24. Liu Y., Chen B.P., Lu M., Zhu Y., Stemerman M.B., Chien S., and Shyy J.Y. Shear stress activation of SREBP1 in endothelial cells is mediated by integrins. Arterioscler. Thromb. Vasc. Biol. 22 (2002) 76-81
25. Mark K.S., and Davis T.P. Cerebral microvascular changes in permeability and tight junctions induced by hypoxia-reoxygenation. Am. J. Physiol. Heart Circ. Physiol. 282 (2002) H1485-H1494
26. Mckenzie J.A., and Ridley A.J. Roles of Rho/ROCK and MLCK in TNF-alpha-induced changes in endothelial morphology and permeability. J. Cell. Physiol. 213 (2007) 221-228
27. Miebach S., Grau S., Hummel V., Rieckmann P., Tonn J.C., and Goldbrunner R.H. Isolation and culture of microvascular endothelial cells from gliomas of different WHO grades. J. Neurooncol. 76 (2006) 39-48
28. Nitta T., Hata M., Gotoh S., Seo Y., Sasaki H., Hashimoto N., Furuse M., and Tsukita S. Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. J. Cell Biol. 161 (2003) 653-660
29. Nomura T., Inamura T., and Black K.L. Intracarotid infusion of bradykinin selectively increases blood-tumor permeability in 9L and C6 brain tumors. Brain Res. 658 (1994) 62-66
30. Nusrat A., Turner J.R., and Madara J.L. Molecular physiology and pathophysiology of tight junctions IV. Regulation of tight junctions by extracellular stimuli: nutrients, cytokines, and immune cells. Am. J. Physiol.: Gastrointest. Liver Physiol. 279 (2000) G851-G857
31. Salama N.N., Eddington N.D., and Fasano A. Tight junction modulation and its relationship to drug delivery. Adv. Drug Deliv. Rev. 58 (2006) 15-28
32. Samoto K., Perng G.C., Ehtesham M., Liu Y., Wechsler S.L., Nesburn A.B., Black K.L., and Yu J.S. A herpes simplex virus type 1 mutant deleted for gamma 34.5 and LAT kills glioma cells in vitro and is inhibited for in vivo reactivation. Cancer Gene Ther. 8 (2001) 269-277
33. Shalak V., Guigou L., Kaminska M., Wautier M.P., Wautier J.L., and Mirande M. Characterization of p43(ARF), a derivative of the p43 component of multiaminoacyl-tRNA synthetase complex released during apoptosis. J. Biol. Chem. 282 (2007) 10935-10943
34. Shen L., and Turner J.R. Actin depolymerization disrupts tight junctions via caveolae-mediated endocytosis. Mol. Biol. Cell 16 (2005) 3919-3936
35. Stamatovic S.M., Keep R.F., Kunkel S.L., and Andjelkovic A.V. Potential role of MCP-1 in endothelial cell tight junction 'opening': signaling via Rho and Rho kinase. J. Cell Sci. 116 (2003) 4615-4628
36. Tandle A.T., Mazzanti C., Alexander H.R., Roberts D.D., and Libutti S.K. Endothelial monocyte activating polypeptide-II induced gene expression changes in endothelial cells. Cytokine 30 (2005) 347-358
37. Tsai B.M., Wang M., Clauss M., Sun P., and Meldrum D.R. Endothelial monocyte-activating polypeptide II causes NOS-dependent pulmonary artery vasodilation: a novel effect for a proinflammatory cytokine. Am. J. Physiol. Regul. Integr. Comp. Physiol. 287 (2004) R767-771
38. Wolburg H., and Lippoldt A. Tight junctions of the blood-brain barrier: development, composition and regulation. Vascul. Pharmacol. 38 (2002) 323-337
39. Wolburg H., Wolburg-Buchholz K., Kraus J., Rascher-Eggstein G., Liebner S., Hamm S., Duffner F., Grote E.H., Risau W., and Engelhardt B. Localization of claudin-3 in tight junctions of the blood-brain barrier is selectively lost during experimental autoimmune encephalomyelitis and human glioblastoma multiforme. Acta Neuropathol. 105 (2003) 586-592
40. Yuan F., Salehi H.A., Boucher Y., Vasthare U.S., Tuma R.F., and Jain R.K. Vascular permeability and microcirculation of gliomas and mammary carcinomas transplanted in rat and mouse cranial windows. Cancer Res. 54 (1994) 4564-4568